Knee osteoarthritis (KOA) is a very challenging condition to treat and can be resistant to medications, procedures, and even surgery. Surgery may not be an option for some patients due to obesity or comorbidities. Regenerative medicine utilizing stem cells, platelet rich plasma (PRP), amniotic fluid,...
Placental-derived tissues are a known source of anti-inflammatory and immune modulating factors. Published pilot data on amniotic suspension allograft (ASA) for the treatment of osteoarthritis (OA) demonstrated safety and trends for improved pain and function. ...
: Degenerative joint and tendon injuries remain difficult to treat, with few effective conservative treatment optionsavailable. Regenerative approaches aim to promote the inherent healing capacity of injured tissues. Micronized dehydratedhuman amnion/chorion membrane (dHACM) injection is an emerging regenerative option with promising preclinical results ...
Osteoarthritis (OA) of the knee is a leading cause of chronic pain and disability in the United States. Current treatmentoptions primarily target OA symptoms reserving surgical intervention and knee replacement for those who fail conservativemeasures ...
The use of intra-articular therapies as sources of growth factors, anti-inflammatory mediators, and medicinal signaling cells for osteoarthritis (OA) is rapidly evolving. Amnion, chorion, amniotic fluid, and the umbilical cord are distinct placental tissues that have been investigated for use in OA. Amniotic membrane (AM)...
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! ...